ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 160 filers reported holding ITEOS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 6.56 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,035,723 | -14.1% | 277,235 | +3.9% | 0.00% | 0.0% |
| Q2 2023 | $3,532,936 | +3.0% | 266,838 | +5.9% | 0.00% | 0.0% |
| Q1 2023 | $3,429,979 | -30.8% | 252,019 | -0.7% | 0.00% | 0.0% |
| Q4 2022 | $4,954,507 | +7.6% | 253,687 | +4.9% | 0.00% | 0.0% |
| Q3 2022 | $4,606,000 | -4.2% | 241,813 | +3.7% | 0.00% | 0.0% |
| Q2 2022 | $4,807,000 | -24.5% | 233,285 | +17.9% | 0.00% | 0.0% |
| Q1 2022 | $6,368,000 | -26.3% | 197,884 | +6.6% | 0.00% | 0.0% |
| Q4 2021 | $8,643,000 | +81.4% | 185,634 | +5.2% | 0.00% | 0.0% |
| Q3 2021 | $4,764,000 | +7.6% | 176,446 | +2.2% | 0.00% | 0.0% |
| Q2 2021 | $4,428,000 | -32.8% | 172,603 | -10.4% | 0.00% | 0.0% |
| Q1 2021 | $6,586,000 | +47.6% | 192,709 | +46.1% | 0.00% | 0.0% |
| Q4 2020 | $4,463,000 | +41.7% | 131,943 | +3.4% | 0.00% | 0.0% |
| Q3 2020 | $3,149,000 | – | 127,664 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,738,785 | $29,989,696 | 16.06% |
| MPM BioImpact LLC | 1,745,943 | $19,118,076 | 5.10% |
| Saturn V Capital Management LP | 994,756 | $10,892,578 | 4.56% |
| Boxer Capital, LLC | 1,804,058 | $19,754,435 | 1.05% |
| RA Capital Management | 4,417,259 | $48,368,986 | 0.95% |
| 683 Capital Management, LLC | 810,000 | $8,869,500 | 0.69% |
| Ikarian Capital, LLC | 346,471 | $3,793,857 | 0.46% |
| Ikarian Capital, LLC | 3,056 | $3,346,320 | 0.40% |
| BVF INC/IL | 1,259,476 | $13,791,262 | 0.37% |
| DAFNA Capital Management LLC | 98,560 | $1,079,232 | 0.34% |